000 | 01759 a2200553 4500 | ||
---|---|---|---|
005 | 20250516085540.0 | ||
264 | 0 | _c20120813 | |
008 | 201208s 0 0 eng d | ||
022 | _a1527-1315 | ||
024 | 7 |
_a10.1148/radiol.12111209 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYu, Jie | |
245 | 0 | 0 |
_aUS-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results. _h[electronic resource] |
260 |
_bRadiology _cJun 2012 |
||
300 |
_a900-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aBiopsy |
650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdiagnostic imaging |
650 | 0 | 4 | _aChi-Square Distribution |
650 | 0 | 4 | _aContrast Media |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGadolinium DTPA |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney Neoplasms _xdiagnostic imaging |
650 | 0 | 4 | _aMagnetic Resonance Imaging |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMicrowaves _xtherapeutic use |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPhospholipids |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aStatistics, Nonparametric |
650 | 0 | 4 | _aSulfur Hexafluoride |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTomography, X-Ray Computed |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aUltrasonography, Interventional |
700 | 1 | _aLiang, Ping | |
700 | 1 | _aYu, Xiao-ling | |
700 | 1 | _aCheng, Zhi-gang | |
700 | 1 | _aHan, Zhi-yu | |
700 | 1 | _aMu, Meng-juan | |
700 | 1 | _aWang, Xiao-hui | |
773 | 0 |
_tRadiology _gvol. 263 _gno. 3 _gp. 900-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1148/radiol.12111209 _zAvailable from publisher's website |
999 |
_c21697256 _d21697256 |